Achaogen, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Achaogen, Inc.
Quantité totale PI 52
Rang # Quantité totale PI 27 021
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 712 178
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

0 0
0 1
45 5
1
 
Dernier brevet 2019 - Modular synthesis of aminoglycos...
Premier brevet 2003 - Business methods for commerciali...
Dernière marque 2018 - ZEMDRI
Première marque 2008 - ACHAOGEN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2018 P/S Antibiotics.
Invention Synthesis of antibacterial aminoglycoside analogs. The present disclosure relates to novel method...
Invention Modular synthesis of aminoglycosides. The present disclosure relates to novel methods for prepari...
Invention Aminoglycosides and uses thereof. Provided herein are aminoglycoside compounds, such as compounds...
P/S Antibiotics
Invention Reporter microorganisms and uses thereof. Provided herein are polynucleotides containing a regula...
2017 Invention Plazomicin antibodies and methods of use. The present invention provides anti-plazomicin antibodi...
Invention 6-phenylpyrido[2,3-d]pyrimidine compounds as antibacterial agents. The disclosure relates to anti...
Invention Combination products for the treatment of bacterial infections and methods of producing or dosing...
Invention Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections. P...
Invention Antibacterial agents. The disclosure relates to antibacterial compounds having the Formula (I), w...
Invention Antibacterial agents. Antibacterial compounds of formula (I) are provided: Antibacterial compo...
Invention Screening methods for identifying antibodies that bind cell surface epitopes. Provided are assay...
Invention Screening methods for identifying antibodies that bind cell surface epitopes. Provided are assays...
2016 Invention Antibacterial agents. Antibacterial compounds of formula (I) are provided: as well as stereoiso...
2014 Invention Antibacterial agents. Antibacterial compounds of formula (I) are provided, as well as stereoisome...
2012 Invention Antibacterial aminoglycoside analogs. Compounds having antibacterial activity are disclosed. The ...
Invention Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymet...
Invention Antibacterial aminoglycoside analogs. Compounds having antibacterial activity are disclosed. The...
2011 Invention Combination therapies using antibacterial aminoglycoside compounds. Methods for treating a bacte...
Invention Antibacterial amiinoglycoside analogs. Compounds having antibacterial activity are disclosed. The...
Invention Treatment of urinary tract infections with antibacterial aminoglycoside compounds. A method for ...
Invention Aminoglycoside dosing regimens. The present invention provides new aminoglycoside dosing regimen...
Invention Hydroxamic acid derivatives and their use in the treatment of bacterial infections. Antibacterial...
Invention Antibacterial compositions. The present invention provides a methods and pharmaceutical composit...
Invention Antibacterial fluoroquinolone analogs. Compounds having antibacterial activity are disclosed. Th...
Invention Carbacephem beta-lactam antibiotics. Carbacephem β-lactam antibiotics having the following chemi...
2010 Invention Antibacterial fluoroquinolone analogs. Compounds having antibacterial activity are disclosed. The...
Invention Combination therapies using antibacterial aminoglycoside compounds. Methods for treating a bacter...
Invention Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections...
2008 P/S Anti-bacterial prescription and non-prescription drugs; pharmaceutical preparations, namely, the...